New patent for Chemocentryx drug TAVNEOSBy DrugPatentWatch – Make Better Decisions / April 30, 2024 Annual Drug Patent Expirations for TAVNEOS Tavneos is a drug marketed by Chemocentryx and is included in one NDA. It is available from one supplier. There are three patents protecting…Source